These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37419269)

  • 1. Neuropeptide Y: Direct vasoconstrictor and facilitatory effects on P2X1 receptor-dependent vasoconstriction in human small abdominal arteries.
    Del Carmen Gonzalez-Montelongo M; Meades JL; Fortuny-Gomez A; Fountain SJ
    Vascul Pharmacol; 2023 Aug; 151():107192. PubMed ID: 37419269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y facilitates P2X1 receptor-dependent vasoconstriction via Y1 receptor activation in small mesenteric arteries during sympathetic neurogenic responses.
    Gonzalez-Montelongo MDC; Fountain SJ
    Vascul Pharmacol; 2021 Feb; 136():106810. PubMed ID: 33181321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE
    Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of potentiation of Leu31 Pro34 neuropeptide Y on adrenergic and purinergic transmission in isolated canine splenic artery.
    Yang XP; Chiba S
    Jpn J Pharmacol; 2000 Jul; 83(3):197-205. PubMed ID: 10952068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNA.
    Modin A; Malmström RE; Meister B
    Neuropeptides; 1999 Aug; 33(4):253-9. PubMed ID: 10657500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of neuropeptide Y1 and neuropeptide Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes.
    Grundemar L; Krstenansky JL; Håkanson R
    Eur J Pharmacol; 1993 Mar; 232(2-3):271-8. PubMed ID: 8467862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SR 120107A antagonizes neuropeptide Y Y1 receptor mediated sympathetic vasoconstriction in pigs in vivo.
    Malmström RE; Modin A; Lundberg JM
    Eur J Pharmacol; 1996 Jun; 305(1-3):145-54. PubMed ID: 8813545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Existence of both neuropeptide Y, Y1 and Y2 receptors in pig spleen: evidence using subtype-selective antagonists in vivo.
    Malmström RE
    Life Sci; 2001 Sep; 69(17):1999-2005. PubMed ID: 11589515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced Y1-receptor-mediated vasoconstrictive action of neuropeptide Y (NPY) in superior mesenteric arteries in portal hypertension.
    Wiest R; Jurzik L; Moleda L; Froh M; Schnabl B; von Hörsten S; Schölmerich J; Straub RH
    J Hepatol; 2006 Mar; 44(3):512-9. PubMed ID: 16324766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and molecular cloning of vascular neuropeptide Y receptor subtypes in pig and dog.
    Malmström RE; Hökfelt T; Björkman JA; Nihlén C; Byström M; Ekstrand AJ; Lundberg JM
    Regul Pept; 1998 Sep; 75-76():55-70. PubMed ID: 9802394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo receptor characterization of neuropeptide Y-induced effects in consecutive vascular sections of cat skeletal muscle.
    Ekelund U; Erlinge D
    Br J Pharmacol; 1997 Feb; 120(3):387-92. PubMed ID: 9031740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of vasoconstriction and Ca2+ currents mediated by neuropeptide Y Y2 receptors.
    Lewis CJ; Evans RJ; Neild TO
    J Smooth Muscle Res; 1999; 35(5-6):147-56. PubMed ID: 10733151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NPY Y2 receptor agonist, N-acetyl [Leu28,Leu31]NPY24-36, reduces renal vasoconstrictor activity in anaesthetised dogs.
    Mahns DA; Kelly C; McCloskey DI; Potter EK
    J Auton Nerv Syst; 1999 Oct; 78(1):10-7. PubMed ID: 10589818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
    Gibbs JL; Diogenes A; Hargreaves KM
    Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y receptor subtypes, Y1 and Y2.
    Wahlestedt C; Grundemar L; Håkanson R; Heilig M; Shen GH; Zukowska-Grojec Z; Reis DJ
    Ann N Y Acad Sci; 1990; 611():7-26. PubMed ID: 2174225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gβγ subunit signalling underlies neuropeptide Y-stimulated vasoconstriction in rat mesenteric and coronary arteries.
    Lin J; Scullion L; Garland CJ; Dora K
    Br J Pharmacol; 2023 Dec; 180(23):3045-3058. PubMed ID: 37460913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of noradrenaline and neuropeptide Y on rat mesenteric microvessel contraction.
    Chen H; Fetscher C; Schäfers RF; Wambach G; Philipp T; Michel MC
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):314-23. PubMed ID: 8692287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.
    Abounader R; Villemure JG; Hamel E
    Br J Pharmacol; 1995 Oct; 116(4):2245-50. PubMed ID: 8564255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.